BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5
130 results:

  • 1. Immunohistochemical and Molecular Characteristics of Anogenital Papillary Hidradenomas.
    Karpathiou G; Sim A; Picot T; Mekhzoumi K; Chauleur C; Péoc'h M
    Am J Dermatopathol; 2024 Feb; 46(2):79-82. PubMed ID: 38055985
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]    [Full Text] [Related]  

  • 3. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
    Kansikas M; Vähätalo L; Kantelinen J; Kasela M; Putula J; Døhlen A; Paloviita P; Kärkkäinen E; Lahti N; Arnez P; Kilpinen S; Alcala-Repo B; Pylvänäinen K; Pöyhönen M; Peltomäki P; Järvinen HJ; Seppälä TT; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Nyström M
    Cancer Res Commun; 2023 Mar; 3(3):361-370. PubMed ID: 36875157
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort.
    Zhong CS; Horiguchi M; Uno H; Ukaegbu C; Chittenden A; LeBoeuf NR; Syngal S; Nambudiri VE; Yurgelun MB
    J Am Acad Dermatol; 2023 Jun; 88(6):1282-1290. PubMed ID: 36773823
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis.
    Wei B; Gu J; Gao B; Bao Y; Duan R; Li Q; Xie F
    Br J Dermatol; 2023 Jan; 188(1):64-74. PubMed ID: 36689509
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study.
    Grandt CL; Brackmann LK; Poplawski A; Schwarz H; Hummel-Bartenschlager W; Hankeln T; Kraemer C; Marini F; Zahnreich S; Schmitt I; Drees P; Mirsch J; Grabow D; Schmidberger H; Binder H; Hess M; Galetzka D; Marron M
    Mol Med; 2022 Sep; 28(1):105. PubMed ID: 36068491
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors.
    Gambichler T; Finis C; Abu Rached N; Scheel CH; Becker JC; Lang K; Käfferlein HU; Brüning T; Abolmaali N; Susok L
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1241-1247. PubMed ID: 35419731
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Early age of onset and broad cancer spectrum persist in msh6- and PMS2-associated Lynch syndrome.
    Liu YL; Cadoo KA; Maio A; Patel Z; Kemel Y; Salo-Mullen E; Catchings A; Ranganathan M; Kane S; Soslow R; Ceyhan-Birsoy O; Mandelker D; Carlo MI; Walsh MF; Shia J; Markowitz AJ; Offit K; Stadler ZK; Latham A
    Genet Med; 2022 Jun; 24(6):1187-1195. PubMed ID: 35346574
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diffuse Large B-Cell Lymphoma, Epstein-Barr Virus -Positive Kappa Monotypic Plasma Cell Proliferation and Invasive Carcinoma, Developing in a Child With Defective Mismatch Repair.
    Uner M; Saglam A; Tukun A; Aydın B; Akyol A; Uner A
    Pediatr Dev Pathol; 2022; 25(3):339-344. PubMed ID: 35227120
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sebaceous Carcinoma Arising in Ovarian Teratoma: First Report Associated With Germline Mismatch Repair Gene Mutation.
    Murray J; McIlwaine P; Morrison PJ; McCluggage WG
    Int J Gynecol Pathol; 2022 Nov; 41(6):608-614. PubMed ID: 35077082
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD).
    Vassantachart JM; Zacher NC; Teng JMC
    Pediatr Dermatol; 2022 Jan; 39(1):91-93. PubMed ID: 34787334
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Muir-Torre syndrome: a case of unusual coexisting genetic mutations.
    Cino D; Drumm C; Sheahan K; D'Arcy C; Nolan N; Hoti E; Winter D; O'Duffy F; Dolan R; Moriarty B
    Clin Exp Dermatol; 2022 Mar; 47(3):602-604. PubMed ID: 34762321
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma.
    Gambichler T; Ganjuur N; Tannapfel A; Vogt M; Scholl L; Abu Rached N; Bruckmüller S; Skrygan M; Becker JC; Käfferlein HU; Brüning T; Lang K
    Curr Oncol; 2021 Aug; 28(5):3316-3322. PubMed ID: 34590599
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mutational landscape in Uveal Melanoma.
    Mastronikolis S; Adamopoulou M; Papouliakos S; Manoli A; Katsinis S; Makri O; Monastirioti AE; Tsiambas E; Georgakopoulos C
    J BUON; 2021; 26(4):1194-1197. PubMed ID: 34564968
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular Genetics of Sebaceous Neoplasia.
    North JP
    Surg Pathol Clin; 2021 Jun; 14(2):273-284. PubMed ID: 34023105
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3'UTR of the msh6 gene.
    Cini G; Carnevali I; Sahnane N; Chiaravalli AM; Dell'Elice A; Maestro R; Pin E; Bestetti I; Radovic S; Armelao F; Viel A; Tibiletti MG
    Cancer Genet; 2021 Jun; 254-255():1-10. PubMed ID: 33516942
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma.
    Torres-Cabala C; Li-Ning-Tapia E; Hwu WJ
    Arch Med Res; 2020 Nov; 51(8):827-838. PubMed ID: 32950263
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
    Vasan K; Anand S; Satgunaseelan L; Asher R; Low H; Palme CE; Lee JH; Clark JR; Gupta R
    J Surg Oncol; 2020 Dec; 122(8):1755-1760. PubMed ID: 32926758
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.